FDA Should be More Active in Regulating Devices, Say Academicians

The General Accountability Office (GAO) should press the FDA to stop being passive in its oversight of device safety and instead take a more bold and active role, according to several academicians who collaborated on an opinion piece in the peer-reviewed healthcare journal Health Affairs.
Source: Drug Industry Daily